CD44 and cancer: CD44 is a type I transmembrane glycoprotein known to facilitate cell adhesion, spreading, migration, invasion, ROS defense, and drug resistance in a variety of cancer types (Misra et al, 2005a; Ishimoto et al, 2011; Zoller, 2011; Montgomery et al, 2012; Hiraga et al, 2013).